Cite
Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer.
MLA
Lin Long, et al. “Potential Therapeutic Targets of the JAK2/STAT3 Signaling Pathway in Triple-Negative Breast Cancer.” Frontiers in Oncology, May 2024, pp. 01-17. EBSCOhost, https://doi.org/10.3389/fonc.2024.1381251.
APA
Lin Long, Xiangyu Fei, Liucui Chen, Liang Yao, & Xiaoyong Lei. (2024). Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer. Frontiers in Oncology, 01-17. https://doi.org/10.3389/fonc.2024.1381251
Chicago
Lin Long, Xiangyu Fei, Liucui Chen, Liang Yao, and Xiaoyong Lei. 2024. “Potential Therapeutic Targets of the JAK2/STAT3 Signaling Pathway in Triple-Negative Breast Cancer.” Frontiers in Oncology, May, 01-17. doi:10.3389/fonc.2024.1381251.